STATEMENTS OF OPERATIONS (USD $)	3 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
OTHER INCOME	$ 113,144	$ 15,000
OPERATING EXPENSES:
Research and development (excluding R&D depreciation of R&D depreciation of $41,673 and $104,864)	4,019,541	2,924,722
Depreciation and amortization	56,699	133,450
General & administrative	1,971,214	2,001,285
Total operating expenses	6,047,454	5,059,457
OPERATING LOSS	(5,934,310)	(5,044,457)
GAIN ON DERIVATIVE INSTRUMENTS	1,610,817	2,746,198
INTEREST INCOME	31,757	29,415
INTEREST EXPENSE	(42,682)	(41,402)
NET LOSS	(4,334,418)	(2,310,246)
ISSUANCE OF ADDITIONAL SHARES DUE TO RESET PROVISIONS	(1,117,447)	0
NET LOSS AVAILABLE TO COMMON SHAREHOLDERS	$ (5,451,865)	$ (2,310,246)
NET LOSS PER COMMON SHARE
BASIC	$ (0.11)	$ (0.08)
DILUTED	$ (0.15)	$ (0.18)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
BASIC	48,215,919	28,311,602
DILUTED	48,215,919	28,311,602